Kit C. B. Roes

4.5k citations

143 papers · 2.9k indexed · 1 hit paper · h-index 28

Statistics and Probability top 0.5%
- Statistical Methods in Clinical Trials 43
- Advanced Causal Inference Techniques 22
- Statistical Methods and Bayesian Inference 10
Statistics, Probability and Uncertainty top 0.5%
- Meta-analysis and systematic reviews 13
- Advanced Statistical Process Monitoring 11
Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life 42
Psychiatry and Mental health top 5%
Cardiology and Cardiovascular Medicine top 5%
Management Science and Operations Research
- Optimal Experimental Design Methods 10
Neurology
- Amyotrophic Lateral Sclerosis Research 9

Co-authors: Rolf H. H. Groenwold Arno W. Hoes Olaf H. Klungel Anthonius de Boer Karel G.M. Moons A. Rogier T. Donders Frank E. Harrell Ronald J. M. M. Does
Cited by: Statistics and Probability Statistics, Probability and Uncertainty Economics and Econometrics
Journals: JAMA (1 paper)Circulation (2 papers)Nature Communications (2 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Kit C. B. Roes

134 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Kit C. B. Roes

Since Specialization

Citations

This map shows the geographic impact of Kit C. B. Roes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit C. B. Roes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit C. B. Roes more than expected).

Fields of papers citing papers by Kit C. B. Roes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit C. B. Roes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit C. B. Roes. The network helps show where Kit C. B. Roes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kit C. B. Roes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kit C. B. Roes Line = papers co-authored together Kit C. B. Roes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Evidence 2030 Clinical Pharmacology & Therapeutics ·Peter Arlett,Denise Umuhire,Patrice Verpillat,Paolo Foggi,Ulla Liminga,Bruno Sepodes,Marianne Lunzer,Brian Aylward,Spiros Vamvakas,Kit C. B. Roes,Frank Pétavy,Steffen Thirstrup,María Jesús Lamas,Emer Cooke,Karl Broich	2025	5
2	Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health Clinical Pharmacology & Therapeutics ·Luís Pinheiro,Peter Arlett,Kit C. B. Roes,Flora T. Musuamba,Gabriel Westman,Zaide Frias,H.J. Hamann,Joaquim Berenguer Jornet,Iftekhar Khan,Jeppe Fuglsang Larsen,Karl Broich,Emer Cooke	2024	2
3	Combining evidence from clinical trials in conditional or accelerated approval Pharmaceutical Statistics ·Manja Deforth,Charlotte Micheloud,Kit C. B. Roes,Leonhard Held	2023	2
4	Hybrid Controlled Clinical Trials Using Concurrent Registries in Amyotrophic Lateral Sclerosis: A Feasibility Study Clinical Pharmacology & Therapeutics ·Ruben P. A. van Eijk,Leonard H. van den Berg,Kit C. B. Roes,Lü Tian,Tze Leung Lai,Lorene M. Nelson,Chenyu Li,Anna Scowcroft,Jesus Garcia‐Segovia,Ying Lü	2023	2
5	Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board BJPsych Open ·Bram W C Storosum,Cedrine Steinz,Sem E Cohen,Taina Mattila,Wim van den Brink,Kit C. B. Roes,Lieuwe de Haan,Damiaan Denys,Jasper B. Zantvoord	2023	0
6	Recurrent events analysis with piece-wise exponential additive mixed models Statistical Modelling ·Jordache Ramjith,Andreas Bender,Kit C. B. Roes,Marianne A. Jonker	2022	5
7	Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies Psychiatry Research ·Bram W C Storosum,Taina Mattila,Tamar Wohlfarth,Christine C. Gispen‐de Wied,Kit C. B. Roes,Wim van den Brink,Lieuwe de Haan,Damiaan Denys,Jasper B. Zantvoord	2022	15
8	Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy JACC. Cardiovascular imaging ·Anne G. Raafs,Jacqueline L Vos,Michiel T.H.M. Henkens,Bram O. Slurink,Job A.J. Verdonschot,D G A Bossers,Kit C. B. Roes,Suzanne C. Gerretsen,Christian Knackstedt,Mark R. Hazebroek,Robin Nijveldt,Stéphane Heymans	2022	52
9	Medical Specialists' Perspectives on the Influence of Electronic Medical Record Use on the Quality of Hospital Care: Semistructured Interview Study JMIR Human Factors ·Rube van Poelgeest,A.J.P. Schrijvers,Albert Boonstra,Kit C. B. Roes	2021	6
10	In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials Nature Communications ·Ali Sarrami‐Foroushani,Toni Lassila,Michael MacRaild,Joshua Asquith,Kit C. B. Roes,James V. Byrne,Alejandro F. Frangi	2021	48
11	The SNAP Trial: 2-Year Results of a Double-Blind Multicenter Randomized Controlled Trial of a Silicon Nitride Versus a PEEK Cage in Patients After Lumbar Fusion Surgery Global Spine Journal ·R.F.M.R. Kersten,F. Cumhur Öner,Mark P. Arts,Marian Mitroiu,Kit C. B. Roes,Arthur de Gast,Steven M. van Gaalen	2021	10
12	Efficacy gap between phase II and subsequent phase III studies in oncology British Journal of Clinical Pharmacology ·Rick A. Vreman,Svetlana V. Belitser,Ana T.M. Mota,Anke M. Hövels,Wim Goettsch,Kit C. B. Roes,Hubert G.M. Leufkens,Aukje K. Mantel‐Teeuwisse	2020	10
13	Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand British Journal of Clinical Pharmacology ·Frank Pétavy,Lorenzo Guizzaro,Inês Antunes dos Reis,Steven Teerenstra,Kit C. B. Roes	2019	14
14	Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial BMJ Open ·Linda P.T. Joosten,Sander van Doorn,Arno W. Hoes,Melchior C. Nierman,N. Wiersma,Huiberdina L. Koek,Martin E W Hemels,Menno V. Huisman,Kit C. B. Roes,Rutger M. van den Bor,W F Buding,Frans H. Rutten,Geert‐Jan Geersing	2019	11
15	Multimodal, automated detection of nocturnal motor seizures at home: Is a reliable seizure detector feasible? Epilepsia Open ·Judith van Andel,Constantin Ungureanu,Johan Arends,Francis Tan,Johannes van Dijk,George Petkov,Stiliyan Kalitzin,Thea Gutter,Al de Weerd,Ben Vledder,Roland D. Thijs,Ghislaine J. M. W. van Thiel,Kit C. B. Roes,Frans S. S. Leijten	2017	47
16	Validation of multisource electronic health record data: an application to blood transfusion data BMC Medical Informatics and Decision Making ·Loan R. van Hoeven,Martine C. de Bruijne,Peter Kemper,Maria M.W. Koopman,Jan M.M. Rondeel,Anja Leyte,Hendrik Koffijberg,Mart P. Janssen,Kit C. B. Roes	2017	10
17	[A proactive approach to risks: from responding tot leading]. PubMed ·Marieke Zegers,Gijs Hesselink,Kit C. B. Roes,Wytske W. Geense,Hub Wollersheim	2015	1
18	Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study European Neuropsychopharmacology ·Chong Guan Ng,Marco P. Boks,Kit C. B. Roes,Nor Zuraida Zainal,Ahmad Hatim Sulaiman,Tan Seng Beng,Niek J. de Wit	2014	37
19	Justification of exclusion criteria was underreported in a review of cardiovascular trials Journal of Clinical Epidemiology ·Amand F. Schmidt,Rolf H. H. Groenwold,Johannes J. M. van Delden,Yuri van der Does,Olaf H. Klungel,Kit C. B. Roes,Arno W. Hoes,Rieke van der Graaf	2014	22
20	Statistical Methods to Monitor Risk Factors in a Clinical Database Circulation Cardiovascular Quality and Outcomes ·Sabrina Siregar,Kit C. B. Roes,Albert H.M. van Straten,Michiel L. Bots,Yolanda van der Graaf,Lex A. van Herwerden,Rolf H. H. Groenwold	2013	4

About Kit C. B. Roes

Kit C. B. Roes is a scholar working on Statistics and Probability, Statistics, Probability and Uncertainty and Economics and Econometrics, having authored 143 papers that have together received 2.9k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (43 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers), Advanced Causal Inference Techniques (22 papers), Meta-analysis and systematic reviews (13 papers), Advanced Statistical Process Monitoring (11 papers), Optimal Experimental Design Methods (10 papers), Statistical Methods and Bayesian Inference (10 papers) and Amyotrophic Lateral Sclerosis Research (9 papers). The work is most often cited by research in Statistics and Probability (645 citations), Statistics, Probability and Uncertainty (377 citations) and Economics and Econometrics (529 citations). Kit C. B. Roes has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Rolf H. H. Groenwold, Arno W. Hoes, Olaf H. Klungel, Anthonius de Boer, Karel G.M. Moons, A. Rogier T. Donders, Frank E. Harrell, Ronald J. M. M. Does, Ingeborg van der Tweel and Stavros Nikolakopoulos. Their work appears in journals such as JAMA, Circulation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact